Полиартрит, ассоциированный с COVID-19 (клинический случай)
https://doi.org/10.14412/1996-7012-2021-5-76-79
Аннотация
В статье приводится описание клинического наблюдения дебюта полиартрита после перенесенного COVID-19. Представлены клинические данные и результаты лабораторных и инструментальных методов обследования в динамике, а также подходы к терапии. В обсуждении отражены современные взгляды на причины развития суставного синдрома после SARS-CoV-2, указано на необходимость внимательного изучения анамнеза, клинических и лабораторных данных пациентов с COVID-19.
Об авторах
Е. С. Аронова
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»
Россия
Россия
Евгения Сергеевна Аронова
115522, Москва, Каширское шоссе, 34А
Б. С. Белов
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»
Россия
Россия
115522, Москва, Каширское шоссе, 34А
Литература
1. Yokogawa N, Minematsu N, Katano H, Suzuki T. Case of acute arthritis following SARS-CoV-2 infection. Ann Rheum Dis. 2020 Jun 26;annrheumdis-2020-218281. doi: 10.1136/annrheumdis-2020-218281.Online ahead of print.
2. Saricaoglu EM, Hasanoglu I, Guner R. The first reactive arthritis case associated with COVID-19. J Med Virol. 2021 Jan;93(1):192-3. doi: 10.1002/jmv.26296. Epub 2020 Jul 19.
3. De Stefano L, Rossi S, Montecucco C, Bugatti S. Transient monoarthritis and psoriatic skin lesions following COVID-19. Ann Rheum Dis. 2020 Aug 4;annrheumdis-2020-218520. doi: 10.1136/annrheumdis-2020-218520. Online ahead of print.
4. Liew IY, Mak TM, Cui L, et al. A case of reactive arthritis secondary to coronavirus disease 2019 infection. J Clin Rheumatol. 2020 Sep;26(6):233. doi: 10.1097/RHU.0000000000001560.
5. Ono K, Kishimoto M, Shimasaki T, et al. Reactive arthritis after COVID-19 infection. RMD Open. 2020 Aug;6(2):e001350. doi: 10.1136/rmdopen-2020-001350.
6. Alivernini S, Cingolani A, Gessi M, et al. Comparative analysis of synovial inflammation after SARS-CoV-2 infection. Ann Rheum Dis. 2020 Jul 6;annrheumdis-2020-218315. doi: 10.1136/annrheumdis-2020-218315.Online ahead of print.
7. Skendros P, Mitsios A, Chrysanthopoulou A, et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest. 2020 Nov 2;130(11):6151-7. doi: 10.1172/JCI141374.
8. Ahmed S, Zimba O, Gasparyan AY. COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol. 2021 Jul;40(7):2611-9. doi: 10.1007/s10067-021-05691-x. Epub 2021 Mar 17.
9. Sawadogo SA, Dighero-Kemp B, Ouedraogo DD, et al. How NETosis could drive «post-COVID-19 syndrome» among survivors. Immunol Lett. 2020 Dec;228:35-7. doi: 10.1016/j.imlet.2020.09.005. Epub 2020 Sep 29.
10. Garcia LF, Response I. Immune response, inflammation, and the clinical spectrum of COVID-19. Front Immunol. 2020 Jun 16;11:1441. doi: 10.3389/fimmu.2020.01441. eCollection 2020.
11. McGonagle D, Sharif K, O’Regan A, et al. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020 Jun;19(6):102537. doi: 10.1016/j.autrev.2020.102537. Epub 2020 Apr 3.
12. Beringer A, Miossec P. Systemic effects of IL-17 in inflammatory arthritis. Nat Rev Rheumatol. 2019 Aug;15(8):491-501. doi: 10.1038/s41584-019-0243-5. Epub 2019 Jun 21.
13. Pacha O, Sallman MA, Evans SE. COVID-19: a case for inhibiting IL-17? Nat Rev Immunol. 2020 Jun;20(6):345-346. doi: 10.1038/s41577-020-0328-z.
14. Odak I, Barros-Martins J, Bosnjak B, et al. Reappearance of effector T cells is associated with recovery from COVID-19. EBioMedicine. 2020 Jul;57:102885. doi: 10.1016/j.ebiom.2020.102885. Epub 2020 Jul 7.
15. Canas CA. The triggering of post- COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals. Med Hypotheses. 2020 Dec;145:110345. doi: 10.1016/j.mehy.2020.110345.Epub 2020 Oct 14.
16. Arango MT, Perricone C, Kivity S, et al. HLA-DRB1 the notorious gene in the mosaic of autoimmunity. Immunol Res. 2017 Feb; 65(1):82-98. doi: 10.1007/s12026-016-8817-7.
17. Blank M, Barzilai O, Shoenfeld Y. Molecular mimicry and autoimmunity. Clin Rev Allergy Immunol. 2007 Feb;32(1):111-8. doi: 10.1007/BF02686087.
18. Kanduc D, Shoenfeld Y. Human papillomavirus epitope mimicry and autoimmunity: the molecular truth of peptide sharing. Pathobiology. 2019;86(5-6):285-95. doi: 10.1159/000502889. Epub 2019 Oct 8.
19. Lorente L, Martin MM, Franco A, et al. HLA genetic polymorphisms and prognosis of patients with COVID-19. Med Intensiva (Engl Ed). 2021 Mar;45(2):96-103. doi: 10.1016/j.medin.2020.08.004. Epub 2020 Sep 6.
20. Tomita Y, Ikeda T, Sato R, Sakagami T. Association between HLA gene polymorphisms and mortality of COVID-19: an in silico analysis. Immun Inflamm Dis. 2020 Dec; 8(4):684-94. doi: 10.1002/iid3.358.Epub 2020 Oct 13.
21. Novelli A, Andreani M, Biancolella M, et al. HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients. HLA. 2020 Nov;96(5):610-4. doi: 10.1111/tan.14047. Epub 2020 Sep 3.
22. Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020 Jun; 76:233-5. doi: 10.1016/j.jocn.2020.04.062.Epub 2020 Apr 15.
23. Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barre syndrome associated with SARS-CoV-2. N Engl J Med. 2020 Jun 25; 382(26):2574-6. doi: 10.1056/NEJMc 2009191. Epub 2020 Apr 17.
24. Manganotti P, Pesavento V, Buoite Stella A, et al. Miller fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2. J Neurovirol. 2020 Aug;26(4):605-6. doi: 10.1007/s13365-020-00858-9. Epub 2020 Jun 11.
25. Zhang Y, Cao W, Jiang W, et al. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients. J Thromb Thrombolysis. 2020 Oct;50(3):580-6. doi: 10.1007/s11239-020-02182-9.
26. Tsao HS, Chason HM, Fearon DM. Immune Thrombocytopenia (ITP) in a pediatric patient positive for SARS-CoV-2. Pediatrics. 2020 Aug;146(2):e20201419. doi: 10.1542/peds.2020-1419. Epub 2020 May 21.
27. Zulfiqar AA, Lorenzo-Villalba N, Hassler P, Andres E. Immune thrombocytopenic Purpura in a patient with Covid-19. N Engl J Med. 2020 Apr 30;382(18):e43. doi: 10.1056/NEJMc2010472. Epub 2020 Apr 15.
28. Bonometti R, Sacchi MC, Stobbione P, et al. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection. Eur Rev Med Pharmacol Sci. 2020 Sep; 24(18):9695-7. doi: 10.26355/eurrev_202009_23060.
29. Jones VG, Mills M, Suarez D, et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr. 2020 Jun;10(6): 537-40. doi: 10.1542/hpeds.2020-0123.Epub 2020 Apr 7.
30. Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020 Jun 6;395(10239):1771-8. doi: 10.1016/S0140-6736(20)31103-X. Epub 2020 May 13.
31. Megremis S, Walker TDJ, He X, et al. Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis. Ann Rheum Dis. 2020 Oct;79(10):1383-6. doi: 10.1136/annrheumdis-2020-217522. Epub 2020 May 22.
32. Halpert G, Shoenfeld Y. SARS-CoV-2, the autoimmune virus. Autoimmun Rev. 2020 Dec;19(12):102695. doi: 10.1016/j.autrev.2020. 102695. Epub 2020 Oct 28.
33. Cleary SJ, Pitchford SC, Amison RT, et al. Animal models of mechanisms of SARSCoV-2 infection and COVID-19 pathology. Br J Pharmacol. 2020 Nov;177(21):4851-65. doi: 10.1111/bph.15143. Epub 2020 Jul 19.
Рецензия
При поддержке: Исследование выполнено в рамках темы «Коморбидные инфекции при ревматических заболеваниях и проблемы безопасности антиревматической терапии» (АААА-А19-119021190148-3).
Для цитирования:
Аронова Е.С., Белов Б.С. Полиартрит, ассоциированный с COVID-19 (клинический случай). Современная ревматология. 2021;15(5):76-79. https://doi.org/10.14412/1996-7012-2021-5-76-79
For citation:
Aronova E.S., Belov B.S. Polyarthritis associated with COVID-19 (clinical case). Modern Rheumatology Journal. 2021;15(5):76-79. (In Russ.) https://doi.org/10.14412/1996-7012-2021-5-76-79
Просмотров: 1295
Послать статью по эл. почте 